"10.1371_journal.pone.0136833","plos one","2015-08-28T00:00:00Z","Jost B Jonas; Ya Xing Wang; Qi Zhang; Yi Liu; Liang Xu; Wen Bin Wei","Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Science Key Lab, Beijing, China; Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University of Heidelberg, Germany; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China","Conceived and designed the experiments: JBJ YXW LX WBW. Performed the experiments: JBJ YXW QZ YL LX WBW. Analyzed the data: JBJ YXW. Contributed reagents/materials/analysis tools: LX WBW JBJ. Wrote the paper: JBJ YXW QZ YL LX WBW.","JBJ‚ÄConsultant for Allergan Inc.; Merck Sharp & Dohme Co., Inc.; Alimera Co.; Boehringer Ingelheim Co., Sanofi Co. Patent holder with Biocompatible UK Ltd. (Title: Treatment of eye diseases using encapsulated cells encoding and secreting neuroprotective factor and / or anti-angiogenic factor; Patent number:: 20120263794), and patent application with university of Heidelberg (Title: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; Europ√§ische Patentanmeldung 15 000 771.4). There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2015","08","Jost B Jonas","JBJ",6,TRUE,4,6,2,6,TRUE,TRUE,FALSE,0,NA,FALSE
